Yuriy Sirenko
Yuriy Sirenko is an expert in Cardiology at National Scientific Center "M.D. Strazhesko Institute of Cardiology" (Ukraine). As of October 2026, ScienceLeadR ranks Yuriy Sirenko in the top 1% of experts in Ukraine for Hypertension. Yuriy Sirenko has authored 104 publications, the most recent in 2025, and is an investigator in 7 clinical trials. SLR score: 377 (community average: 125). How the SLR is computed.
LeadR Profile
Cardiology
Subspecialties: Pulmonology - Public Health - Critical Care
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 1999 - 2024
Number : 104
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Hemodynamics and Phosphodiesterase-5 Inhibitor Treatment Associated with Survival in Pulmonary Hypertension in Interstitial Lung Disease: A PVRI GoDeep Meta-Registry Analysis. PMID 40772955 — registries, phosphodiesterase 5 inhibitors, hypertension, pulmonary, phosphoric diester hydrolases, critical care, cyclic nucleotide phosphodiesterases, type 5, therapeutics, hemodynamics, lung diseases, interstitial | Am J Respir Crit Care Med | 2025 | 0 |
| 2025 ESC Clinical Consensus Statement on mental health and cardiovascular disease: developed under the auspices of the ESC Clinical Practice Guidelines Committee. PMID 40878270 — cardiovascular diseases, cardiology, mental health | Eur Heart J Top journal | 2025 | 2 |
| Survival Outcomes and Impact of Targeted PAH Therapy in Portopulmonary Hypertension in the PVRI GoDeep Meta-Registry. PMID 40636151 — registries, hypertension, hypertension, pulmonary, therapeutics, survival rate | Pulm Circ | 2025 | 2 |
| SMAD5 as a novel gene for familial pulmonary arterial hypertension. PMID 39631055 — cells, research design, genes, hypertension, diagnostic techniques and procedures, biochemistry, genetics, cell survival, pulmonary arterial hypertension, apoptosis | Clin Sci (Lond) | 2024 | 1 |
| Association of Phosphodiesterase-5 Inhibitor Treatment With Improved Survival in Pulmonary Hypertension Associated With COPD in the Pulmonary Vascular Research Institute GoDeep Meta-Registry. PMID 39182575 — registries, phosphodiesterase 5 inhibitors, hypertension, comorbidity, mortality, hypertension, pulmonary, phosphoric diester hydrolases, pulmonary disease, chronic obstructive, thoracic diseases, cyclic nucleotide phosphodiesterases, type 5, transplants, therapeutics | Chest | 2024 | 5 |
Clinical Studies 7
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Main Topics
Cohort/Consortium Investigators 1
LeadR Networks
Main global connection map